drugset / Trial / NCT06277635
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
RandomizedParallel-groupDouble-blindTreatment
Summary
To study the effect of silymarin against methotrexate-induced liver injury in rheumatic diseases including rheumatoid arthritis, psoriatric arthritis and psoriasis
Timeline
- Start
- 2024-02-01
- Primary completion
- 2025-04
- Completion
- 2025-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Silymarin | Traditional medicine (herbal / TCM) | 140 mg | Oral |